help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 23, 2007
Molecular Endocrinology, doi:10.1210/me.2006-0539
A more recent version of this article appeared on November 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
21/11/2725    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brayman, M. J.
Right arrow Articles by Carson, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brayman, M. J.
Right arrow Articles by Carson, D. D.

Submitted on December 15, 2006
Accepted on August 7, 2007

MUC1 EXPRESSION IS REPRESSED BY PIASy

Melissa Jo Brayman, Neeraja Dharmaraj, Errin Lagow, and Daniel D. Carson*

Department of Reproductive Medicine, University of California, San Diego, School of Medicine, La Jolla, CA 92093-0674, USA; Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA, Ordway Research Institute, Cancer Center, Albany, NY 12208, USA

* To whom correspondence should be addressed. E-mail: dcarson{at}udel.edu.

MUC1 is a transmembrane glycoprotein that modulates the interaction between the embryo and the uterine epithelial cell surface. MUC1 also is a tumor marker and has been implicated in the protection of cancer cells from immune cell attack, as well as in cell signaling in some tumors. We and others have shown that MUC1 expression is activated by progesterone (P), tumor necrosis factor-{alpha} (TNF-{alpha}), and interferon-{gamma} (IFN-{gamma}). Here we demonstrate that MUC1 expression is down-regulated by over-expression of members of the protein inhibitor of activated signal transducer and activator of transcription (PIAS) family, PIAS1, PIAS3, PIASx{alpha}, PIASx{beta}, and PIASy, in human uterine epithelial cell lines, HES and HEC-1A, and in a breast cancer cell line, T47D. Treatments with P, TNF-{alpha}, and IFN-{gamma} were unable to overcome the repression by PIASy. PIASy repression of basal, P- and TNF-{alpha}-stimulated MUC1 promoter activity was not dependent on the PIASy sumoylation domain. In contrast, PIASy suppression of IFN-{gamma} activated MUC1 promoter activity was dependent on the PIASy sumoylation domain. PIASy and progesterone receptor B (PRB) were localized to the nucleus upon P treatment, and siRNA knock-down of PIASy resulted in an increase in P-mediated stimulation of MUC1 protein expression. Over-expression of PIASy did not affect PRB binding to the MUC1 promoter, but surprisingly let to a loss of the corepressor, NCoR, which was recruited to the promoter in response to P. Collectively, these data indicate that PIASy may be a useful target for down-regulation of MUC1 expression in various contexts.


Key words: MUC1 • PIAS • PIASy • progesterone receptor

NURSA Molecule Pages Link:

Nuclear Receptors:   PR
Coregulators:   ARIP3  |  PIAS1  |  PIAS3  |  PIAS4  |  SRC-1  |  AIB1  |  NCOR  |  SMRT
Ligands:   Progesterone  |  R5020






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society